Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Filings indexed 368 across all filing types
Latest filing 2026-06-12 Proxy Solicitation & In…
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a formal convening notice for an Extraordinary Shareholders’ Meeting (임시주주총회 소집공고) detailing date, agenda items (share consolidation, articles amendments), voting procedures, and related information. It is sent to shareholders in advance to inform them of matters to be voted on and to solicit proxy instructions. This fits “Proxy Solicitation & Information Statement” (PSI) rather than a results announcement or actual annual/interim report.
2026-06-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a detailed proxy solicitation (“의결권 대리행사 권유 참고서류”) providing information on proxy voting procedures, agenda items for the shareholder meeting, soliciting parties, and voting methods. It is not merely an announcement but the full proxy statement sent to shareholders to request their votes. This matches the Proxy Solicitation & Information Statement category (PSI).
2026-06-12 Korean
주식병합결정
Share Issue/Capital Change Classification · 92% confidence The document is an official corporate announcement detailing a share consolidation (“주식병합”) decision, including pre- and post-consolidation share counts, schedule, board resolution date, and related procedures. This is a capital structure change (share consolidation), matching the Share Issue/Capital Change category.
2026-06-10 Korean
[기재정정]주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 64% confidence The document is a corporate regulatory disclosure in Korean detailing the convocation resolution for an extraordinary shareholders’ meeting (임시주주총회 소집결의), including the date, agenda items (share consolidation and article amendments), and record dates. It is not the minutes or results of the meeting, nor does it provide financial statements or act as an audit report. It is part of the proxy solicitation materials (notice of meeting and agenda) sent to shareholders to request votes, fitting the definition of a Proxy Solicitation & Information Statement (PSI).
2026-06-10 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 93% confidence The document is titled “분기보고서 6.5 (주)알파에이아이” covering the period from 2026-01-01 to 2026-03-31. It contains detailed interim financial disclosures: corporate overview, subsidiaries, capital changes, share capital tables, management changes, and statutory information. This is the full quarterly report itself (not merely an announcement or summary), thus fitting the definition of an Interim / Quarterly Report. Q1 2026
2026-05-15 Korean
주주총회소집결의 (임시주주총회)
Regulatory Filings Classification · 63% confidence The document is a resolution to convene an extraordinary shareholders’ meeting (임시주주총회 소집결의) – it provides date, time, place, record date, and board resolution details. It is a general regulatory announcement of an upcoming shareholders’ meeting rather than the meeting materials themselves or the results. It does not contain financial statements or proxy solicitation details beyond the notice. This best fits into the catch-all Regulatory Filings category (RNS).
2026-05-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.